People with MS should be aware of the growing range of treatment options available to them.
“I think the MS landscape has changed hugely over the last 20 years. In the mid-90s, we had the introduction of the ‘injectables’ which made a significant difference to the MS population. Over the last 10 years – I was diagnosed back in 2004 – a whole new generation of treatments has become available. I think the real difference now is that with subclinical activity there used to be nothing that could be done about it; but now we have treatments that have been proved to be effective, that slow down atrophy, slow down relapse rate, to manage the MRI activity. So now we can do something about it, I think it's more important than ever that patients become aware of the options available to them.”